Decades of research have generated knowledge and tools that, in theory, could prevent all new HIV infections and ultimately eliminate AIDS. Reality falls far short, in part due to major pressing unmet needs, many of which fall within two domains: Continuum of Care (assuring that all HIV-infected individuals are diagnosed, connected to care, and maintained in care); and Personalized HIV Care (assuring optimally safe and effective therapy based on understanding determinants of inter-individual variability). The proposed Tennessee Center for AIDS Research (TN-CFAR) is located in the Southeastern US, the region with the greatest number of new HIV infections, and of persons living with HIV. Under the leadership of Prof. Simon Mallal (recruited to Vanderbilt to lead this Center) we have forged a unique partnership between a research- intensive institution (Vanderbilt University, VU), an academic health sciences center focused on minority and underserved populations (Meharry Medical College, MMC), and an academically engaged state health department (Tennessee Department of Health, TDH). Our vision is to have transformative, local and global translational impact. Guided by this vision, our mission is to coordinate institutional and community resources and focus efforts on high-priority targets to most effectively reduce the burden of HIV/AIDS and generalize these benefits nationally and globally. We will leverage complementary strengths of VU, MMC, and TDH to focus research efforts on unmet needs. This strategy we will also most effectively serve the traditional CFAR roles of institutional leadership, core service, and fosterig career development of junior investigators. We will focus on four specific aims: 1) To foster collaborations between VU, MMC, and TDH that focus resources and research to improve the continuum of care in Tennessee and beyond; 2) To coordinate research into determinants of interindividual variability in response to HIV interventions so as to improve personalized HIV care, outcomes, and resource utilization; 3) To create and act upon new opportunities for HIV clinical/translational research at MMC, and between MMC and VU; and 4) To develop and grow a new emphasis on HIV-focused community engaged research that will pervade this CFAR.

Public Health Relevance

Overall - NARRATIVE The Tennessee CFAR (TN-CFAR) is an HIV/AIDS research collaboration between Vanderbilt University, Meharry Medical College, and the Tennessee State Department of Health. The TN- CFAR aims to enhance HIV/AIDS-related research by coordinating institutional and community resources, with the goal of reducing the burden of HIV/AIDS in our state and generalizing these benefits nationally and internationally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI110527-04
Application #
9461946
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
2015-04-01
Project End
2020-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Dash, Sabyasachi; Balasubramaniam, Muthukumar; Dash, Chandravanu et al. (2018) Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs. J Vis Exp :
McDonnell, Wyatt J; Koethe, John R; Mallal, Simon A et al. (2018) High CD8 T-Cell Receptor Clonality and Altered CDR3 Properties Are Associated With Elevated Isolevuglandins in Adipose Tissue During Diet-Induced Obesity. Diabetes 67:2361-2376
Norton, Allison Eaddy; Konvinse, Katherine; Phillips, Elizabeth J et al. (2018) Antibiotic Allergy in Pediatrics. Pediatrics 141:
Trubiano, Jason A; Grayson, M Lindsay; Thursky, Karin A et al. (2018) How antibiotic allergy labels may be harming our most vulnerable patients. Med J Aust 208:469-470
Rebeiro, Peter F; McPherson, Tristan D; Goggins, Kathryn M et al. (2018) Health Literacy and Demographic Disparities in HIV Care Continuum Outcomes. AIDS Behav 22:2604-2614
Phillips, Elizabeth J (2018) NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS. Trans Am Clin Climatol Assoc 129:74-87
Liu, Qi; Li, Chun; Wanga, Valentine et al. (2018) Covariate-adjusted Spearman's rank correlation with probability-scale residuals. Biometrics 74:595-605
Karnes, Jason H; Miller, Matthew A; White, Katie D et al. (2018) Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Annu Rev Pharmacol Toxicol :
Buchanan, Ashley L; Vermund, Sten H; Friedman, Samuel R et al. (2018) Assessing Individual and Disseminated Effects in Network-Randomized Studies. Am J Epidemiol 187:2449-2459
Kim, Whan B; Worley, Brandon; Holmes, James et al. (2018) Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol 79:1150-1152

Showing the most recent 10 out of 126 publications